4//SEC Filing
PureTech Health LLC 4
Accession 0000950170-24-082232
CIK 0001850266other
Filed
Jul 7, 8:00 PM ET
Accepted
Jul 8, 7:42 PM ET
Size
7.8 KB
Accession
0000950170-24-082232
Insider Transaction Report
Form 4
Akili, Inc.AKLI
PureTech Health plc
10% Owner
Transactions
- Disposition from Tender
Common Stock
2024-07-02−12,527,477→ 0 total(indirect: See footnote)
PureTech Health LLC
10% Owner
Transactions
- Disposition from Tender
Common Stock
2024-07-02−12,527,477→ 0 total(indirect: See footnote)
Footnotes (2)
- [F1]Reflects disposition of shares of common stock (each, a "Share") of the Issuer at a price per Share of $0.4340 (the "Offer Price") pursuant to the terms of that certain Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 29, 2024, by and among the Issuer, Virtual Therapeutics Corporation, a Delaware corporation ("Parent"), and Alpha Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent ("Purchaser"). Purchaser completed a tender offer for shares of common stock of the Issuer and thereafter merged with and into the Issuer, effective as of July 2, 2024 (the "Effective Time"), with the Issuer surviving the merger. As of the Effective Time, each Share held by the Reporting Person was converted into the Offer Price.
- [F2]PureTech Health LLC is the record holder of all of the securities reported in this Form 4. PureTech Health plc is the sole member of PureTech Health LLC, and has the power to direct the voting and disposition of securities held by PureTech Health LLC.
Documents
Issuer
Akili, Inc.
CIK 0001850266
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001727395
Filing Metadata
- Form type
- 4
- Filed
- Jul 7, 8:00 PM ET
- Accepted
- Jul 8, 7:42 PM ET
- Size
- 7.8 KB